<DOC>
	<DOCNO>NCT01261546</DOCNO>
	<brief_summary>STUDY JUSTIFICATION 1 . Scientific evidence usefulness corticosteroid use infectious disease : Corticosteroids along antibiotic use improve survival infectious process provide long term benefit improve symptom many others . 2 . Clinical Observation : investigator observe patient parapneumonic pleural effusion associate bronchospasm treat corticosteroid bronchospasm , evolve heal patient treated corticosteroid ( average admission day 10 vs. 17 ) . 3 . Rationale : anti-inflammatory effect rationale use dexamethasone inhibitor inflammatory response observe first dose parenteral antibiotic bacterial meningitis . A similar effect likely occur pneumonia pleural effusion . It therefore hypothesize Dexamethasone could inhibit excessive inflammatory response mesothelial inflammatory cell early phase parapneumonic empyema , reduce severity hence complication . OBJECTIVES 1 . Principal : investigate dexamethasone 0,25mg/kg q.i.d . added standard antibiotic therapy reduces time resolution parapneumonic pleural effusion . 2 . Secondary : 2.1 . Evaluate effect dexamethasone 0,25mg/kg q.i.d . added standard antibiotic therapy development complication pleural effusion episode . 2.2 . Evaluate incidence severe non severe adverse event associate new treatment versus standard therapy . METHODS 1 . Study design : exploratory ( pilot ) , randomize , double blind , placebo control , parallel stratify design , multicentric . 2 . Participating Hospitals ( n=56 , 7 patient per center ) : - Hospital Infanta Sofía ( S. Sebastián de los Reyes , Madrid ) . - Hospital Universitario de Getafe - Hospital Universitario Ramón Cajal , Madrid . - Hospital Universitario Materno-Infantil Carlos Haya , Málaga . - Hospital Infantil La Paz , Madrid . - Hospital U. Gregorio Marañón - Hospital U. Príncipe de Asturias - Hospital Virgen de la Salud , Toledo 3 . Endpoints : 3.1 . Primary : time resolution . 3.2 . Secondary endpoint : 1 . Effectiveness : number child complication . 2 . Safety ( expect number : none ) . ) Hyperglycemia ii ) Signs gastrointestinal bleeding iii ) Need transfusion iv ) Oropharyngeal Candidiasis v ) Allergic reaction vi ) Other adverse reaction describe Medication Guide . 4 . Treatment arm : 3.1 . Control ( 0 ) - Normal saline 0,6 ml/kg , IV , q.i.d . 2 day . - Cefotaxime 150 mg/kg , IV , q.d . discharge criterion present . - Ranitidine 5 mg/kg IV , q.d . 2 day . - Amoxicillin- Clavulanic acid 80mg/kg p.o. , q.d . 15 day . 3.2 . Study treatment : ( 1 ) - dexamethasone 0,25mg/kg , IV , q.i.d . 2 day . - Cefotaxime 150 mg/kg , IV , q.d . discharge criterion present - Ranitidine 5 mg/kg IV , q.d . 2 day - Amoxicillin/Clavulanic acid orally ( 80mg/kg/day ) 15 day . 4 . INCLUSION CRITERIA - Patients 1 14 year old . - Presence pneumonia diagnose clinical radiographic criterion : cough , fever radiological consolidation . - Evidence pleural effusion .</brief_summary>
	<brief_title>Clinical Trial Corticoids For Empyema And Pleural Effusion In Children</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Empyema</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Cefotaxime</mesh_term>
	<mesh_term>Cefoxitin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Patients 1 14 year old . Presence pneumonia diagnose clinical radiographic criterion : cough , fever radiological consolidation . Evidence pleural effusion . Allergy drug include study . Immunodeficiency .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>pleural effusion , empyema , corticoid , dexamethasone</keyword>
</DOC>